Site Search
Search Results
30 Patient and Provider Groups Warn that Mifepristone Ruling Threatens All FDA-approved Drugs
WASHINGTON, D.C. – Our organizations, representing patients with serious health conditions, condemn Judge Kacsmaryk’s decision which threatens to restrict access to a Food and Drug Administration (FDA)- approved ... for Hippocratic Medicine et al v FDA et al, sets a dangerous precedent that erodes an institution critical to Americans having access to the care they need. For decades, the FDA has ensured the safety of drugs and treatments in the United States. The FDA’s processes for assessing a ... of America Muscular Dystrophy Association National Alliance on Mental Illness (NAMI) National Coalition for Cancer Survivorship National Health Council National Hemophilia Foundation National Multiple Sclerosis Society National Organization for Rare Disorders National Psoriasis ...
Wisconsin Teen (and ACS CAN volunteer) shares how research saved his leg & and his life
... a briefing at the U.S. Capitol.ξ His message was very clear a new treatment developed through research funded by the National Institutes of Health (NIH) saved his leg, and possibly his life. As you can imagine, cancer research means a lot to me and many other cancer patients who have ... I need the federal government to help with me, he said. We need the government to stand with us and continue funding the National Institutes of Health in their cancer research efforts. After the briefing, Ian and his mother, Kay, one of ACS CAN's lead volunteers in Wisconsin, had meetings ... federally funded cancer research had on his life. Kay Lock also shared how IanÈs cancer affected their family, and how the palliative care that Ian received as a cancer patient made the experience easier for both Ian and the family. To watch Ian at the briefing, click here . ...
ACS CAN Letter: Proposed Changes to Medicare Drug Coverage Could Delay Cancer Patients’ Access to Treatment
Washington, D.C.—Today the American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Department Health and Human Services (HHS) detailing ways in which proposed changes to Medicare Part D’s six protected classes could jeopardize cancer ... – including step therapy and prior authorization – to limit access to protected class drug therapies. The comment letter details how cancer care often requires specialized treatment targeted at a patient’s specific tumor and that such treatments are rarely interchangeable. In ... “can lead to patients not filling their prescriptions or underutilizing medications. Prescription drug noncompliance can lead to poorer health outcomes for the beneficiary as well as increased costs to the Medicare program.” Additionally, the letter raises alarm about patient ...
Television and Digital Ad Campaign Calls on HHS Secretary Azar to Stop Proposed Changes to ‘Six Protected Classes’
... The ads will run on television and social media and feature actual cancer survivors and Medicare beneficiaries urging the Department of Health and Human Services (HHS) Secretary Alex Azar to protect cancer patients’ lives by halting the proposed changes. The campaign premiered ... and medically appropriate therapies,” said Lisa Lacasse, president of ACS CAN. “If finalized, these proposed changes could undermine health provider recommendations and create significant and potentially life-threatening delays in access to cutting-edge therapies that play a crucial role in cancer care.” The six protected classes policy was established more than a decade ago to ensure Medicare beneficiaries were able to have access to ...
One in Five People With Cancer Participate in Medical Research Studies
... in cancer research. This expanded analysis includes more than 70% of people diagnosed with cancer in the U.S. each year who received care at a variety of clinical settings, from community hospitals and academic medical centers to National Cancer Institute-designated comprehensive ... to patients, we need an inclusive, accurate assessment of current participation to inform these policies,” said Joseph Unger, PhD, MS, a health services researcher and biostatistician at Fred Hutch and lead author of the study. “While we knew that patients play a significant role ... studies were derived solely from government-sponsored trials, the study authors used patient data from a diverse range of trial sponsors and care settings for this analysis. Importantly, the data included settings such as community hospitals, where a majority of U.S. cancer patients ...
New Bipartisan Legislation Would Make It Easier for Cancer Patients to Participate in Clinical Trials
... are not considered as taxable income or counted against income limits for programs such as Medicaid. Additionally, the U.S. Department of Health and Human Services (HHS) would be able to provide grants for community education, outreach and recruitment activities to enable greater ... trial engagement with underrepresented populations. Grant-eligible activities would include working with community trial sites and community health centers, training health care personnel and clinical trial investigators, engaging community stakeholders to encourage clinical trial participation and fostering ...
Misuse of March-In Authority Could Jeopardize Progress in Cancer Research and Prove Ineffective in Intent to Lower Prescription Drug Prices
... innovations over the last 40 years. We share the Administration’s mission to lower drug costs, and no discovery that could improve public health should sit on a shelf or be inaccessible to the public. Nonetheless, we remain concerned about the effectiveness of utilizing march-in ...
ACS CAN members attend town hall call recapping outcome of 2018 election
... Bill spoke last week on ACS CAN’s members-only town hall call that broke down the election results and discussed how the results will affect health care and cancer issues around the country. Bill was joined on the call by ACS CAN volunteers and staff members who talked about Cancer Votes, ACS ...
Hundreds of Cancer Patients, Survivors to Congress: Make Cancer a National Priority
... bills. The House Appropriations Committee already passed a bill that includes a $2 billion increase for the National Institutes of Health (NIH) and a $300 million increase for the National Cancer Institute (NCI). The Senate Appropriations Subcommittee on Labor Health and Human Services will mark-up its funding bill Tuesday. “Thanks to past federal investment in the fight against cancer, research keeps ... will also encourage lawmakers to advance legislation that supports patients’ quality of life by increasing access to palliative or supportive care, which can be provided at any age or stage of illness. They will ask Congress to close a Medicare loophole that often results in surprise ...
Cancer Advocates Call on Congressional Leadership to Advance Swift, Comprehensive Solution for Continued Drug Shortages
... drug shortage crisis continues to have a significant impact on cancer patients. One in every 10 cancer patients and survivors report impacts to care, a majority of whom have had difficulties finding substitute medications (68%) and cited treatment delays (59%), according to a recent survey ... there are 16 oncology drugs listed in the shortage , a number of which don’t have an effective alternative and have led to worse health outcomes for cancer patients. The full text of the letter can be read here. 0 American Cancer Society Cancer Action Network Issues ...
Type
Priority Issue
State
- (-) Remove National filter National
- Georgia (2) Apply Georgia filter
- Minnesota (2) Apply Minnesota filter
- New Jersey (2) Apply New Jersey filter
- North Dakota (2) Apply North Dakota filter
- Tennessee (2) Apply Tennessee filter
- California (1) Apply California filter
- Kentucky (1) Apply Kentucky filter
- Mississippi (1) Apply Mississippi filter
- North Carolina (1) Apply North Carolina filter
- Oklahoma (1) Apply Oklahoma filter